Tuberc Respir Dis > Volume 55(4); 2003 > Article
Tuberculosis and Respiratory Diseases 2003;55(4):395-401.
DOI: https://doi.org/10.4046/trd.2003.55.4.395    Published online October 1, 2003.
A Case of Pulmonary Tuberculosis with Delayed Diagnosis Due to the Temporary Clinical Improvement After Use of Levofloxacin and Amikacin Under the Impression of Community Acquired Pneumonia.
Hee Seok Lee, Young Ae Kang, Jin Young Oh, Jae Ho Lee, Chul Gyu Yoo, Choon Taek Lee, Young Whan Kim, Sung Koo Han, Young Soo Shim, Jae Joon Yim
Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, and Lung Institute, Seoul National University College of Medicine, Korea. yimjj@snu.ac.kr
Abstract
Fluoroquinolone is one of the first-line antibiotics recommended for treating community-acquired pneumonia. However, using fluroquinolones for presumptive community-acquired pneumonia can delay the diagnosis and the treatment of pulmonary tuberculosis because of its strong activity against mycobacteria. Here, we report a case of a 54-year-old female taking immunosuppressants after a renal transplant whose diagnosis of pulmonary tuberculosis was delayed as a result of the use of levofloxacin and amikacin under the original impression of community-acquired pneumonia. This case suggests that clinicians should consider the possibility of pulmonary tuberculosis in the case of a partial response of the pneumonia to flouroquinolones and/or aminoglycosides.
Key Words: Levofloxacin, Amikacin, Pulmonary tuberculosis, Pneumonia, Delayed diagnosis


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next